Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 30, 2026.

Icon

What is Icon?

Icon is drug Discovery and Development Services.

When was Icon founded and where is it based?

Icon was founded in Not specified in the provided context. and is headquartered in Not specified in the provided context..

What does Icon offer?

Icon's core products are Regulatory strategies and intelligence, clinical operability solutions (e.g., for neurologic monoclonal antibodies), biosimilars landscape strategies, network meta-analysis, manufacturing and pharmacy services (rapid small batch formulation, manufacturing, labelling, distribution for clinical trials), outcome measures identification and implementation, cardiac safety solutions, early clinical and bioanalytical solutions, site and patient recruitment solutions, market access and reimbursement consulting, specialty laboratory solutions, pharmacovigilance, and AI-powered platforms such as Orbis (multi-agent platform connecting human expertise, data, and AI across the clinical trial lifecycle) and EngageAI (AI-enhanced voice of the customer feedback platform)..

How is Icon priced?

Icon uses Not specified in the provided context..

Who does Icon target?

Icon serves Pharmaceutical companies, biotech companies (including small & mid-sized biopharma), medical device manufacturers, and patients involved in clinical trials..

What differentiates Icon from competitors?

ICON expands the possibilities of clinical research by integrating human expertise, data, and AI across the clinical trial lifecycle. They offer pragmatic, impactful, and award-winning AI solutions (like Orbis and EngageAI), provide bespoke and seamless solutions for unique sponsor challenges, maintain global regulatory intelligence, and adopt a patient-centric approach to drug development and outcomes measurement.

Official website: https://iconplc.com/

Last analyzed: August 30, 2026

About this profile

This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.

If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile